Our findings indicate that UC-MSC treatment, either alone or as an adjunct to biologic therapy, may inhibit the migration of skin-homing T cells into involved skin in psoriasis, while facilitating the egress of CLA+CD103+ cells (17, 18) into the peripheral circulation. This evidence concerns the gene SELPLG and psoriasis.